Oxidized LDL and NO synthesis-Biomarkers of endothelial dysfunction and ageing

Mechanisms of Ageing and Development

Volumn 151, Issue , 2015, Pages 101-113

  Gradinaru, Daniela ^a,b   Borsa, Claudia ^a   Ionescu, Cristina ^a   Prada, Gabriel Ioan ^a,b  

^a National Institute of Gerontology and Geriatrics   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Ageing; Biomarker; Endothelial dysfunction; Nitric oxide; Oxidized LDL

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN P66; TETRAHYDROBIOPTERIN; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN;

AGING; ATHEROGENESIS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; RISK ASSESSMENT; BLOOD; CARDIOVASCULAR DISEASE; METABOLISM; VASCULAR ENDOTHELIUM;

AGING; BIOMARKERS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 84947044617     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2015.03.003     Document Type: Review

References (126)

1. Armitage M.E., Wingler K., Schmidt H.H., La M. Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J. Mol. Med. (Berl.) 2009, 87(11):1071-1076.
2. Babakr A.T., Elsheikh O.M., Almarzouki A.A., Assiri A.M., Abdalla B.E., Zaki H.Y., Fatani S.H., NourEldin E.M. Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations. Diabetes Metab. Syndr. Obes. 2014, 24(7):513-520.
3. Baur J., Moreno-Villanueva M., Kötter T., Sindlinger T., Bürkle A., Berthold M., Junk M. MARK-AGE: extraction, cleaning and quality control of data. Mech. Aging Dev. Special Issue Biomark. Aging 2015.
4. Bermúdez V., Bermúdez F., Acosta G., Acosta A., Añez J., Andara C., Leal E., Cano C., Manuel V., Hernández R., Israili Z. Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition. Am. J. Ther. 2008, 15(4):326-333.
5. Besler H.T., Comoğlu S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr. Neurosci. 2003, 6(2):189-196.
6. Borsa C., Ionescu C., Gradinaru D. Oxidized LDL and NO synthesis as biomarkers of atherogenesis - correlations with metabolic profile in elderly. Atherogenesis 2012, 473-494. InTech Open Access Publisher, Croatia. S. Parthasarathy (Ed.).
7. Brandão S.A., Izar M.C., Fischer S.M., Santos A.O., Monteiro C.M., Póvoa R.M., Helfenstein T., Carvalho A.C., Monteiro A.M., Ramos E., Gidlund M., Figueiredo Neto A.M., Fonseca F.A. Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control. Am. J. Hypertens. 2010, 23(2):208-214.
8. Bürkle A., Moreno-Villanueva M., Bernhard J., Blasco M., Zondag G., Hoeijmakers J., Toussaint O., Grubeck-Löbenstein B., Mocchegiani E., Collino S., Gonos S., Sikora E., Gradinaru D., Dolle M., Salmon M., Kristensen P., Griffiths H., Libert C., Grune T., Breusing N., Simm A., Franceschi C., Capri M., Talbot D., Caiafa P., Friguet B., Slagboom E., Hervonnen A., Hurme M., Aspinall R. MARK-AGE biomarkers of aging. Mech. Aging Dev. Special Issue Biomark. Aging 2015.
9. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000, 87(10):840-844.
10. Capri M., Moreno-Villanueva M., Zoli M., Scurti M., Pini E., Cevenini E., Borelli V., Schön C., Fiegl S., de Craen A., Hervonnen A., Bernhardtd J., Sikora E., Gonos E., Toussaint O., Grubeck-Loebenstein B., Bürkle A., Franceschi C. MARK-AGE population: from the human model to practical and successful strategies. Mech. Aging Dev. Special Issue Biomark. Aging 2015.
11. Chatterjee A., Black S.M., Catravas J.D. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc. Pharmacol. 2009, 49(4-6):134-140.
12. Chikani G., Zhu W., Eric J. Smart lipids: potential regulators of nitric oxide generation. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E386-E389.
13. Cominacini L., Pasini A.F., Garbin U., Davoli A., Tosetti M.L., Campagnola M., Rigoni A., Pastorino A.M., Lo Cascio V., Sawamura T. Oxidized low-density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of nuclear factor-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 2000, 275(17):12633-12638.
14. Couillard C., Ruel G., Archer W.R., Pomerleau S., Bergeron J., Couture P., Lamarche B., Bergeron N. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J. Clin. Endocrinol. Metab. 2005, 90(12):6454-6459.
15. Crisby M., Kublickiene K., Henareh L., Agewall S. Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels 2009, 24(2):90-95.
16. Dantas A.P., Jiménez-Altayó F., Vila E. Vascular aging: facts and factors. Front. Physiol. 2012, Article 325. 10.3389/fphys.2012.00325.
17. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115(10):1285-1295.
18. Demir M., Kucuk A., Sezer M.T., Altuntas A., Kaya S. Malnutrition-inflammation score and endothelial dysfunction in hemodialysis patients. J. Ren. Nutr. 2010, 20(6):377-383.
19. Dildar K., Sinem F., Gökhan E., Orhan Y., Filiz M. Serum nitrosative stress levels are increased in Alzheimer disease but not in vascular dementia. Alzheimer Dis. Assoc. Disord. 2010, 24(2):194-197.
20. Donato A.J., Eskurza I., Silver A.E., Levy A.S., Pierce G.L., Gates P.E., Seals D.R. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ. Res. 2007, 100(11):1659-1666.
21. Donato A.J., Pierce G.L., Lesniewski L.A., Seals D.R. Role of nuclear factor-kappaB in age-related vascular endothelial dysfunction in humans. Aging Albany (N.Y.) 2009, 1(8):678-680.
22. El Assar M., Angulo J., Vallejo S., Peiró C., Sánchez-Ferrer C.F., Rodríguez-Mañas L. Mechanisms involved in the aging-induced vascular dysfunction. Front. Physiol. 2012, 3:132.
23. Ercan M., Firtina S., Konukoglu D. Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia. Clin. Hemorheol. Microcirc. 2014, 57(4):315-323.
24. Erusalimski J.D. Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 2009, 106(1):326-332.
25. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 1992, 13(4):341-390.
26. Faria A.M., Papadimitriou A., Silva K.C., Lopes de Faria J.M., Lopes de Faria J.B. Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels. Diabetes 2012, 61:1838-1847.
27. Fonseca H.A., Fonseca F.A., Monteiro A.M., Bianco H.T., Boschcov P., Brandão S.A., Juliano L., Gidlund M., Izar M.C. Obesity modulates the immune response to oxidized LDL in hypertensive patients. Cell Biochem. Biophys. 2013, 67(3):1451-1460.
28. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Aging Dev. 2007, 128:92-105.
29. Franzeck F.C., Hof D., Spescha R.D., Hasun M., Akhmedov A., Steffel J., Shi Y., Cosentino F., Tanner F.C., von Eckardstein A., Maier W., Lüscher T.F., Wyss C.A., Camici G.G. Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease. Atherosclerosis 2012, 220:282-286.
30. Ghasemi A., Zahedias S., Azimzadeh I., Azizi F. Increased serum nitric oxide metabolites in dysglycaemia. Ann. Hum. Biol. 2011, 38:577-582.
31. Gradinaru D., Borsa C., Ionescu C., Margina D. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J. Proteomics 2013, 92:313-322.
32. Gradinaru D., Borsa C., Ionescu C., Margina D., Prada G.I., Jansen E. Vitamin D status and oxidative stress markers in the elderly with impaired fasting glucose and type 2 diabetes mellitus. Aging Clin. Exp. Res. 2012, 24(6):595-602.
33. Hayashi T., Yano K., Matsui-Hirai H., Yokoo H., Hattori Y., Iguchi A. Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 2008, 120(3):333-339.
34. Hayashida K., Kume N., Murase T., Minami M., Nakagawa D., Inada T., Tanaka M., Ueda A., Kominami G., Kambara H., Kimura T., Kita T. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome a novel marker for early diagnosis. Circular 2005, 112(6):812-818.
35. Heitzer T., Krohn K., Albers S., Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 2000, 43:1435-1438.
36. Hirata Y., Nagata D., Suzuki E., Nishimatsu H., Suzuki J., Nagai R. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int. Heart J. 2010, 51(1):1-6.
37. Holowatz L.A., Kenney W.L. Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans. J. Physiol. 2011, 589:4787-4797.
38. Holvoet P., De Keyzer D., Jacobs D.R. Oxidized LDL and the metabolic syndrome. Future Lipidol. 2008, 3(6):637-649.
39. Holvoet P., Kritchevsky S.B., Tracy R.P., Mertens A., Rubin S.M., Butler J., Goodpaster B., Harris T.B. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004, 53(4):1068-1073.
40. Holvoet P., Lee D.H., Steffes M., Gross M., Jacobs D.R. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. J. Am. Med. Assoc. 2008, 299(19):2287-2293.
41. Ignarro L.J., Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr. Atheroscler. Rep. 2004, 6(4):281-287.
42. Jin R.C., Loscalzo J. Vascular nitric oxide: formation and function. J. Blood Med. 2010, 1:147-162.
43. Kampus P., Kals J., Ristimäe T., Muda P., Ulst K., Zilmer K., Salonen R.M., Tuomainen T.P., Teesalu R., Zilmer M. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein andoxidized low-density lipoprotein. J. Hypertens. 2007, 25(4):819-825.
44. Kankaanpää J., Turunen S.P., Moilanen V., Hörkkö S., Remes A.M. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease. Neurobiol. Dis. 2009, 33(3):467-472.
45. Kaplon R.E., Gano L.B., Seals D.R. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J. Appl. Physiol. (1985) 2014, 116(2):156-163.
46. Kaplon R.E., Walker A.E., Seals D.R. Plasma norepinephrine is an independent predictor of vascular endothelial function with aging in healthy women. J. Appl. Physiol. (1985) 2011, 111(5):1416-1421.
47. Kim J.Y., Kim O.Y., Paik J.K., Kwon D.Y., Kim H.J., Lee J.H. Association of age-related changes in circulating intermediary lipid metabolites, inflammatory and oxidative stress markers, and arterial stiffness in middle-aged men. AGE 2013, 35:1507-1519.
48. Kobayashi N., Takano M., Hata N., Kume N., Yamamoto M., Yokoyama S., Shinada T., Tomita K., Shirakabe A., Otsuka T., Seino Y., Mizuno K. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography. Int. J. Cardiol. 2013, 168(4):3217-3223.
49. Kolluru G.K., Bir S.C., Kevil C.G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 2012:918267.
50. Kopprasch S., Pietzsch J., Kuhlisch E., Fuecker K., Temelkova-Kurktschiev T., Hanefeld M., Kühne H., Julius U., Graessler J. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002, 51(10):3102-3106.
51. Kuklinska A.M., Mroczko B., Musial W.J., Usowicz-Szarynska M., Sawicki R., Borowska H., Knapp M., Szmitkowski M. Diagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurements. Int. Heart J. 2009, 50(3):341-351.
52. Le N.A. Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesis. Int. J. Mol. Sci. 2015, 16(1):401-419.
53. Li W., Mital S., Ojaimi C., Csiszar A., Kaley G., Hintze, TH Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J. Mol. Cell. Cardiol. 2004, 37(3):671-680.
54. López-Uriarte P., Nogués R., Saez G., Bulló M., Romeu M., Masana L., Tormos C., Casas-Agustench P., Salas-Salvadó J. Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin. Nutr. 2010, 29(3):373-380.
55. Lundberg J.O., Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscl. Thromb. Vasc. Biol. 2005, 25(5):915-922.
56. Mah E., Pei R., Guo Y., Ballard K.D., Barker T., Rogers V.E., Parker B.A., Taylor A.W., Traber M.G., Volek J.S., Bruno R.S. γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation. Free Radical Biol. Med. 2013, 65:1291-1299.
57. Maiolino G., Pedon L., Cesari M., Frigo A.C., Barisa M., Rossitto G., Seccia T.M., Zanchetta M., Rossi G.P. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. Int. J. Cardiol. 2013, 168(1):484-489.
58. Maiolino G., Rossitto G., Caielli P., Bisogni V., Rossi G.P., Calò L.A. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013, 714653.
59. Mangerich A., Burkle A. Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid. Med. Cell. Longev. 2012, 2012:321653.
60. Mazière C., Savitsky V., Galmiche A., Gomila C., Massy Z., Mazière J.C. Oxidized low density lipoprotein inhibits phosphate signaling and phosphate-induced mineralization in osteoblasts. Involvement of oxidative stress. Biochim. Biophys. Acta 2010, 1802(11):1013-1019.
61. Meisinger C., Baumert J., Khuseyinova N., Loewel H., Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005, 112:651e7.
62. Merino J., Ferré R., Girona J., Aguas D., Cabré A., Plana N., Vinuesa A., Ibarretxe D., Basora J., Buixadera C., Masana L. Even low physical activity levels improve vascular function in overweight and obese postmenopausal women. Menopause 2013, 20(10):1036-1042.
63. Michel T., Vanhoutte P.M. Cellular signaling and NO production. Pflugers Arch. 2010, 459(6):807-816.
64. Moncada S., Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 2006, 147(Suppl. 1):S193-S201.
65. Moreau K.L., Meditz A., Deane K.D., Kohrt W.M. Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen deficient postmenopausal women. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H1211-H1218.
66. Moreno-Luna R., Muñoz-Hernandez R., Miranda M.L., Costa A.F., Jimenez-Jimenez L., Vallejo-Vaz A.J., Muriana F.J., Villar J., Stiefel P. Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am. J. Hypertens. 2012, 25(12):1299-1304.
67. Moreno-Villanueva M., Capri M., Breusing N., Sevini F., Ghezzo S., Schön C., de Craen A.J., Hervonnen A., Bernhardt J., Grune T., Franceschi C., Bürkle A. MARK-AGE standard operating procedures (SOPs): a successful effort. Mech. Aging Dev. Special Issue Biomark. Aging 2015.
68. Moreno-Villanueva M., Kötter T., Sindlinger T., Baur J., Bürkle A., Berthold M. MARK-AGE database. Mech. Aging Dev. Special Issue Biomark. Aging 2015.
69. Müller S., König I., Meyer W., Kojda G. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J. Am. Coll. Cardiol. 2004, 44(3):624-631.
70. Muñoz-Torrero J.F., Rivas D., Alonso R., Crespo L., Costo A., Roman M., Martín C., Zamorano J. Influence of lipoprotein (a) on inflammatory biomarkers in metabolic syndrome. South. Med. J. 2012, 105(7):339-343.
71. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006, 15(4):265-279.
72. Nawrot T.S., Staessen J.A. Genetic variation and environmental factors in biological and arterial aging. Verh. K. Acad. Geneeskd. Belg. 2008, 70(5-6):323-338.
73. Nawrot T.S., Staessen J.A., Holvoet P., Struijker-Boudier H.A., Schiffers P., Van Bortel L.M., Fagard R.H., Gardner J.P., Kimura M., Aviv A. Telomere length and its associations with oxidized-LDL: carotid artery distensibility and smoking. Front Biosci. (Elite Ed.) 2010, 2:1164-1168.
74. Nilsson P.M. Early vascular aging (EVA): consequences and prevention. Vasc. Health Risk Manage. 2008, 4(3):547-552.
75. Njajou O.T., Kanaya A.M., Holvoet P., Connelly S., Strotmeyer E.S., Harris T.B., Cummings S.R., Hsueh W.C. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the health, aging and body composition study. Diabetes Metab. Res. Rev. 2009, 25(8):733-739.
76. Obradovic M.M., Trpkovic A., Bajic V., Soskic S., Jovanovic A., Stanimirovic J., Panic M., Isenovic E.R. Interrelatedness between C-reactive protein and oxidized low-density lipoprotein. Clin. Chem. Lab. Med. 2015, 53(1):29-34.
77. Orem A., Yucesan F.B., Orem C., Akcan B., Kural B.V., Alasalvar C., Shahidi F. Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects. J. Clin. Lipidol. 2013, 7(2):123-131.
78. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87(1):315-424.
79. Paik J.K., Chae J.S., Kang R., Kwon N., Lee S.H., Lee J.H. Effect of age on atherogenicity of LDL and inflammatory markers in healthy women. Nutr. Metab. Cardiovasc. Dis. 2013, 23(10):967-972.
80. Parthasarathy S., Litvinov D., Selvarajan K., Garelnabi M. Lipid peroxidation and decomposition - conflicting roles in plaque vulnerability and stability. Biochim. Biophys. Acta 2008, 1781(5):221-231.
81. Perkins K.A., Pershad S., Chen Q., McGraw S., Adams J.S., Zambrano C., Krass S., Emrich J., Bell B., Iyamu M., Prince C., Kay H., Teng J.C., Young L.H. The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R). Naunyn Schmiedebergs Arch. Pharmacol. 2012, 385:27-38.
82. Pierce G.L., Lesniewski L.A., Lawson B.R., Beske S.D., Seals D.R. Nuclear factor-kappaB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 2009, 119(9):1284-1292.
83. Pirillo A., Catapano A.L. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis. Mark. 2013, 35(5):413-418.
84. Pirillo A., Norata G.D., Catapano A.L. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013, 2013:152786.
85. Profumo E., Di Franco M., Buttari B., Masella R., Filesi C., Tosti M.E., Scrivo R., Scarno A., Spadaro A., Saso L., Rigano R. 2012. Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders. Mediators Inflamm. 2012, 2012:503942. 10.1155/2012/503942.
86. Roberts A.C., Porter K.E. Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diabetes Vasc. Dis. Res. 2013, 10(6):472-482.
87. Robman L., McNeil J., Dimitrov P., Dowrick A., Tikellis G., Nicolas C., Cameron J., Guymer R., McGrath B., McCarty C. Methodology of the cardiovascular health and age-related maculopathy (CHARM) study. Ophthalmic Epidemiol. 2004, 11(3):161-179.
88. Rodriguez-Manas L., El-Assar M., Vallejo S., Lopez-Doriga P., Solis J., Petidier R., Montes M., Nevado J., Castro M., Gomez-Guerrero C., Peiro C., Sanchez-Ferrer C.F. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 2009, 8(3):226-238.
89. Rubio A.R., Morales-Segura M.A. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch. Med. Res. 2004, 35(1):1-11.
90. Samsamshariat S.Z., Basati G., Movahedian A., Pourfarzam M., Sarrafzadegan N. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease. Biomark. Med. 2011, 5(3):377-385.
91. Sesso H.D., Buring J.E., Christen W.G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J.E., Glynn R.J., Gaziano J.M. Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized controlled trial. JAMA 2008, 300(18):2123-2133.
92. Shi Y., Cosentino F., Camici G.G., Akhmedov A., Vanhoutte P.M., Tanner F.C., Lüscher T.F. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N terminal kinase in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2090-2097.
93. Shi Y., Lutscher T.F., Camici G.G. Dual role of endothelial nitric oxide synthase in oxidized LDL-induced, p66Shc-mediated oxidative stress in cultured human endothelial cells. PLoS One 2014, 9(9):e107787.
94. Shinozaki K., Nishio Y., Okamura T., Yoshida Y., Maegawa H., Kojima H., Masada M., Toda N., Kikkawa R., Kashiwagi A. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ. Res. 2000, 87:566-573.
95. Sima A., Stancu C., Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009, 335(1):191-203.
96. Simionescu M., Antohe F. Functional ultrastructure of the vascular endothelium: changes in various pathologies. Handb. Exp. Pharmacol. 2006, 176(1):41-69.
97. Steinberg D., Witzum J.L. Oxidized low-density lipoprotein and atherosclerosis. History of discovery. Arterioscler. Thromb. Vasc. Biol. 2010, 30(12):2311-2316.
98. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J. Lipid. Res. 2009, 50:S376-S381.
99. Stojakovic T., Claudel T., Putz-Bankuti C., Fauler G., Scharnagl H., Wagner M., Sourij H., Stauber R.E., Winkler K., März W., Wascher T.C., Trauner M. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis 2010, 209(1):178-183.
100. Sverdlov A.L., Ngo D.T., Chan W.P., Chirkov Y.Y., Horowitz J.D. Aging of the nitric oxide system: are we as old as our NO?. J. Am. Heart Assoc. 2014, 3(4):e000973.
101. Tan K.C.B., Shiu S.W.M., Wong Y., Leng L., Bucala R. Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus. J. Lipid Res. 2008, 49(7):1438-1444.
102. Thorin E., Thorin-Trescases N. Vascular endothelial aging, heartbeat after heartbeat. Cardiovasc. Res. 2009, 84(1):24-32.
103. Tousoulis D., Papageorgiou N., Androulakis E., Siasos G., Latsios G., Tentolouris K., Stefanadis C. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J. Am. Coll. Cardiol. 2013, 62(8):667-676.
104. Tsimikas S., Brilakis E.S., Lennon R.J., Miller E.R., Witztum J.L., McConnell J.P., Kornman K.S., Berger P.B. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 2007, 48(2):425-433.
105. Tsimikas S., Willeit P., Willeit J., Santer P., Mayr M., Xu Q., Mayr A., Witztum J.L., Kiechl S. Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. J. Am. Coll. Cardiol. 2012, 60(21):2218-2229.
106. Ungvari Z., Kaley G., de Cabo R., Sonntag W.E., Csiszar A. Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65A(10):1028-1041.
107. Vaidya D., Szklo M., Cushman M., Holvoet P., Polak J., Bahrami H., Jenny N.S., Ouyang P. Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multi-ethnic study of atherosclerosis. Eur. J. Clin. Nutr. 2011, 65(7):818-825.
108. van der Zwan L.P., Teerlink T., Dekker J.M., Henry R.M.A., Stehouwer C.D.A., Jakobs C., Heine R.J., Scheffer P.G. Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation. J. Lipid Res. 2009, 50(2):342-349.
109. Verhoye E., Langlois M.R. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?. Clin. Chem. Lab. Med. 2009, 47(2):128-137.
110. Verma S., Buchanan M.R., Anderson T.J. Endothelial function testing as a biomarker of vascular disease. Circulation 2003, 108:2054-2059.
111. Violi F., Sanguigni V., Carnevale R., Plebani A., Rossi P., Finocchi A., Pignata C., De Mattia D., Martire B., Pietrogrande M.C., Martino S., Gambineri E., Soresina A.R., Pignatelli P., Martino F., Basili S., Loffredo L. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 2009, 120(16):1616-1622.
112. Volpe C.M., Abreu L.F., Gomes P.S., Gonzaga R.M., Veloso C.A., Nogueira-Machado J.A. The production of nitric oxide, IL-6, and TNF-alpha in palmitate-stimulated PBMNCs is enhanced through hyperglycemia in diabetes. Oxid. Med. Cell. Longev. 2014, 2014:479587.
113. Wadley A.J., Jet J.C.S., van Zanten V., Aldred S. The interactions of oxidative stress and inflammation with vascular dysfunction in aging: the vascular health triad. AGE 2013, 35:705-718.
114. Walker A.E., Kaplon R.E., Lucking S.M., Russell-Nowlan M.J., Eckel R.H., Seals D.R. Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelialnitric oxide synthase in healthy normolipidemic older adults. Hypertension 2012, 60(6):1517-1523.
115. Wang J.C., Bennett M. Aging and atherosclerosis Mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 2011, 111:245-259.
116. Wang Y., Chun O.K., Song W.O. Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients 2013, 5(8):2969-3004.
117. Weinbrenner T., Schröder H., Escurriol V., Fito M., Elosua R., Vila J., Marrugat J., Covas M.I. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am. J. Clin. Nutr. 2006, 83(1):30-35.
118. Wink D.A., Miranda K.M., Espey M.G., Pluta R.M., Hewett S.J., Colton C., Vitek M., Feelisch M., Grisham M.B. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox Signal. 2001, 3(2):203-213.
119. Wu J., Xia S., Kalionis B., Wan W., Sun T. The role of oxidative stress and inflammation in cardiovascular aging. Biomed. Res. Int. 2014, 2014:615312.
120. Wu T., Willett W.C., Rifai N., Shai I., Manson J.E., Rimm E.B. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?. J. Am. Coll. Cardiol. 2006, 48(5):973-979.
121. Xu S., Ogura S., Chen J., Little P.J., Moss J., Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell. Mol. Life Sci. 2013, 70(16):2859-2872.
122. Xu X., Gao X., Potter B.J., Cao J.M., Zhang C. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic. ApoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 2007, 27(4):871-877.
123. Yamamori T., White A.R., Mattagajasingh I., Khanday F.A., Haile A., Qi B., Jeon B.H., Bugayenko A., Kasuno K., Berkowitz D.E., Irani K. p66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction. J. Mol. Cell. Cardiol. 2005, 39(6):992-995.
124. Yubero-Serrano E.M., Delgado-Casado N., Delgado-Lista J., Perez-Martinez P., Tasset-Cuevas I., Santos-Gonzalez M., Caballero J., Garcia-Rios A., Marin C., Gutierrez-Mariscal F.M., Fuentes F., Villalba J.M., Tunez I., Perez-Jimenez F., Lopez-Miranda J. Postprandial antioxidant effect of the Mediterranean diet supplemented with coenzyme Q10 in elderly men and women. Age (Dordr.) 2011, 33(4):579-590.
125. Zhao Z.W., Zhu X.L., Luo Y.K., Lin C.G., Chen L.L. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease. Clin. Cardiol. 2011, 34(3):172-177.
126. Zuliani G., Morieri M.L., Volpato S., Vigna G.B., Tch C.B., Maggio M., Cherubini A., Bandinelli S., Guralnik J.M., Ferrucci L. Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study. Atherosclerosis 2012, 226(1):201-720.